Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients

被引：0
|
作者：
Sara E. Mole
Angela Schulz
Eben Badoe
Samuel F. Berkovic
Emily C. de Los Reyes
Simon Dulz
Paul Gissen
Norberto Guelbert
Charles M. Lourenco
Heather L. Mason
Jonathan W. Mink
Noreen Murphy
Miriam Nickel
Joffre E. Olaya
Maurizio Scarpa
Ingrid E. Scheffer
Alessandro Simonati
Nicola Specchio
Ina Von Löbbecke
Raymond Y. Wang
Ruth E. Williams
机构：
[1] University College London,Korle Bu Teaching Hospital
[2] Universitätsklinikum Hamburg-Eppendorf,Austin Health Victoria
[3] University of Ghana Medical School,Golisano Childrens’ Hospital
[4] University of Melbourne,Regional Coordinating Center for Rare Diseases
[5] Nationwide Children’s Hospital,Department of Surgery, Dentistry, Paediatrics and Gynaecology
[6] Hospital de Niños de La Santísima Trinidad,undefined
[7] Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto,undefined
[8] Coufetery Comms,undefined
[9] University of Rochester Medical Center,undefined
[10] Batten Disease Support and Research Association (BDSRA),undefined
[11] Children’s Hospital of Orange County,undefined
[12] University Hospital Udine,undefined
[13] University of Verona School of Medicine,undefined
[14] Ospedale Pediatrico Bambino Gesù,undefined
[15] Practice for Child Physiotherapy,undefined
[16] Evelina,undefined
[17] London Children’s Hospital,undefined
[18] NIHR Great Ormond Street Hospital Biomedical Research Centre,undefined
[19] Royal Children’s Hospital,undefined
[20] Florey and Murdoch Children’s Research Institutes,undefined
来源：
Orphanet Journal of Rare Diseases | / 16卷
关键词：
Expert mapping; Guideline development program; CLN2; Batten; Neurodegenerative disorder; Key Opinion Leader; Modified-Delphi;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Neuronal ceroidolipofuscinosis type 2 (CLN2) disease: Clinical features, diagnosis and an innovative therapeutic opportunity
    Dallagiacoma, S.
    Di Donato, I.
    Sollazzo, M. T.
    Rufa, A.
    Specchio, N.
    Aiello, C.
    Bertini, E.
    Tedeschi, G.
    Dotti, M. T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 592 - 593
  • [12] CLN2 disease-from early diagnosis early intervention
    Wibbeler, Eva
    Schulz, Angela
    MEDICINE, 2019, 98 (26)
  • [13] Monitoring Neuropsychological Function in CLN2 Disease
    Augustine, E.
    Adams, H.
    Baron, I. S.
    Bjoraker, K.
    Cohen-Pfeffer, J.
    Delaney, K.
    Elmerskog, B.
    Newsom-Davis, I
    Nickel, G.
    Rust, S.
    Shapiro, E.
    Tossebro, A. G.
    Schulz, A.
    ANNALS OF NEUROLOGY, 2018, 84 : S401 - S402
  • [14] Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa
    Schulz, Angela
    Schwering, Christoph
    Wibbeler, Eva
    Westermann, Lena Marie
    Hagenah, Luca
    Lezius, Susanne
    Jha, Ashok
    Hunt, Abigail
    Slasor, Peter
    Reisewitz, Pascal
    Nickel, Miriam
    FRONTIERS IN NEUROLOGY, 2025, 16
  • [15] Neurofilament light is a treatment-responsive biomarker in CLN2 disease
    Ru, Yuanbin
    Corado, Carley
    Soon, Russell K., Jr.
    Melton, Andrew C.
    Harris, Adam
    Yu, Guoying K.
    Pryer, Nancy
    Sinclair, John R.
    Katz, Martin L.
    Ajayi, Temitayo
    Jacoby, David
    Russell, Chris B.
    Chandriani, Sanjay
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (12): : 2437 - 2447
  • [16] OCT Biomarkers in Ocular CLN2 Disease
    Huang, Wei Chieh
    Atiskova, Yevgeniya
    Ohnsman, Christina M.
    Dulz, Simon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [17] Psychometric Validation of the CLN2 Quality of Life Questionnaire in Participants with CLN2 Disease Treated with Cerliponase Alfa
    Due, Christina
    Quinn, Jennifer
    Gissen, Paul
    Schulz, Angela
    Specchio, Nicola
    de los Reyes, Emily
    Butt, Thomas
    HEALTHCARE, 2024, 12 (22)
  • [18] Expert recommendations for the laboratory diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Diagnostic algorithm and best practice guidelines for a timely diagnosis
    Giugliani, Roberto
    Fietz, Michael
    Al-Sayed, Moeenaldeen
    Burke, Derek
    Cohen-Pfeffer, Jessica
    Cooper, Jonathan D.
    Noher de Halac, Ines
    Dvorakova, Lenka
    Izzo, Emanuela
    Jahnova, Helena
    Lukacs, Zoltan
    Mole, Sara
    Pearce, David
    Schulz, Angela
    Specchio, Nicola
    Xin, Winnie
    Miller, Nicole
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S61 - S61
  • [19] Mitochondrial abnormalities in CLN2 and CLN3 forms of Batten disease
    Dawson, G
    Kilkus, J
    Siakotos, AN
    Singh, I
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1996, 29 (2-3) : 227 - 235
  • [20] Cerliponase alfa for CLN2 disease, a promising therapy
    Aylward, Shawn C.
    Pindrik, Jonathan
    Abreu, Nicolas J.
    Cherny, W. Bruce
    O'Neal, Matthew
    de Los Reyes, Emily
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (11): : 445 - 454
12345